Source: Eur Respir J 2014; 43: 675-677



Rating:

Share or cite this content

Citations should be made in the following way:
Fitzgerald Dominic A.. Increased daily activity in cystic fibrosis: time to break out the prescription pad?. Eur Respir J 2014; 43: 675-677

Member's Comments

No comment yet.

Related content which might interest you: Tezacaftor-ivacaftor for the treatment of cystic fibrosis: what’s next? Source: International Congress 2018 – Therapeutic breakthroughs Year in Review Year: 2018 Can step be a maximal test in children with cystic fibrosis? Source: Annual Congress 2009 - Paediatric lung function, imaging and methodology in health and disease Year: 2009 Cystic fibrosis patients: do they profit from altitiude residence? Source: Annual Congress 2006 - Man at altitude: benefits and risks of pre-existing respiratory impairment due to various diseases Year: 2006 The relationship between daily physical activity and exercise performance in adults with cystic fibrosis Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment Year: 2014 Variation in lung function as a marker of adherence to oral and inhaled medication in cystic fibrosis Source: Eur Respir J , 49 (3) 1600987; DOI: 10.1183/13993003.00987-2016 Year: 2017 The treatment burden of cystic fibrosis: a day-to-day experience with treatment as someone with cystic fibrosis Source: Breathe, 17 (1) 210013; 10.1183/20734735.0013-2021 Year: 2021 Activities of daily living in patients with cystic fibrosis Source: Annual Congress 2009 - Physiotherapy aspects in cystic fibrosis and functional assessment Year: 2009 Idiopathic pulmonary fibrosis: time for greater expectations? Source: Eur Respir J, 52 (2) 1801312; 10.1183/13993003.01312-2018 Year: 2018 Intervention trials and ventilation distribution in mild cystic fibrosis lung disease: will it all come out in the wash? Source: Eur Respir J 2011; 37: 757-759 Year: 2011 Recommended shielding against SARS-CoV-2 impacts physical activity levels and adherence to airway clearance therapy in patients with cystic fibrosis Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects Year: 2021 Effect of home intravenous antibiotic treatment on exercise capacity in children with cystic fibrosis Source: Annual Congress 2010 - Gas exchange and paediatric exercise testing Year: 2010 Recombinant human DNase nebulisation in children with cystic fibrosis: before bedtime or after waking up? Source: Eur Respir J 2007; 30: 763-768 Year: 2007 Evolution of lung clearance index during the first year of life in cystic fibrosis Source: Virtual Congress 2021 – Monitoring of lung disease and CFTR function in children with cystic fibrosis Year: 2021 The oral AntibioticS approprIateness score (OASIS) – A novel scoring system to assess antibiotic route in pulmonary exacerbations of cystic fibrosis (CF) Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013 Measuring CFTR function in respiratory epithelial cell cultures: step to individualize treatments in cystic fibrosis? Source: Virtual Congress 2021 – Monitoring of lung disease and CFTR function in children with cystic fibrosis Year: 2021 Effect of high intensity interval exercise rehabilitation in cystic fibrosis Source: International Congress 2017 – Best abstracts in pulmonary rehabilitation and chronic care Year: 2017 Relationships between bronchodilator therapy, resting energy expenditure and systemic inflammation in cystic fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 503s Year: 2003 Does this patient have cystic fibrosis?  Source: International Congress 2017 – GR6 Paediatric Ground Round: an interactive session Year: 2017 Arm functional capacity and activity of daily living in children with primary ciliary dyskinesia and cystic fibrosis Source: International Congress 2019 – Exercise and physiotherapy in patients with asthma, cystic fibrosis, bronchiectasis and primary ciliary dyskinesia Year: 2019